What is the PEERLESS-HF Study?

Clinical research studies are conducted to determine the safety and effectiveness of new, investigational medical devices and therapies. In the PEERLESS-HF study, the HeartNet™ device will be tested in comparison to the current standard of care, which is optimal medical and device therapy (pacemaker or implantable cardioverter-defibrillator) alone. If eligible, you will be randomly assigned to either a treatment group (receiving the HeartNet device and medical therapy) or a control group (receiving medical therapy with no HeartNet device).

Who can participate?

In general, patients who have been diagnosed with heart failure (sometimes also called congestive heart failure, HF or CHF) and meet certain criteria may participate. For the purposes of the PEERLESS-HF clinical research study, that includes:

• Participants must be 18 to 74 years of age;
• have moderate HF (heart failure or congestive heart failure);
• be on HF medications;
• have had HF for more than six months;
• not have had a heart bypass procedure in the past and are not being considered for one in the near future

These are not the only criteria for acceptance into the PEERLESS-HF clinical research study. Only a clinical research study staff member can make the determination.